Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Equity (Unaudited)

v3.25.0.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Parent [Member]
Noncontrolling Interest [Member]
Balance at Oct. 31, 2023 $ 23,371,000 $ 311,000 $ 252,222,000 $ (228,196,000)   $ 24,337,000 $ (966,000)
Balance, shares at Oct. 31, 2023   31,145,219          
Stock option compensation to employees and directors 1,108,000 1,108,000   1,108,000
Stock options issued to consultants 56,000 56,000   56,000
Common stock issued to consultants 96,000 $ 1,000 95,000   96,000
Common stock issued to consultants, shares   29,336          
Common stock issued in an at-the-market offering, net of offering expenses of $68 2,196,000 $ 6,000 2,190,000   2,196,000
Common stock issued in an at-the-market offering, net of offering expenses of $68, shares   555,820          
Common stock issued upon exercise of stock options 67,000 67,000   67,000
Common stock issued upon exercise of stock options, shares   24,000          
Net loss (3,290,000) (3,255,000)   (3,255,000) (35,000)
Balance at Jan. 31, 2024 23,604,000 $ 318,000 255,738,000 (231,451,000)   24,605,000 (1,001,000)
Balance, shares at Jan. 31, 2024   31,754,375          
Balance at Oct. 31, 2024 18,888,000 $ 322,000 260,432,000 (240,750,000) $ (6,000) 19,998,000 (1,110,000)
Balance, shares at Oct. 31, 2024   32,196,862          
Stock option compensation to employees and directors 1,031,000 1,031,000 1,031,000
Stock options issued to consultants 24,000 24,000 24,000
Expenses related to an at-the-market offering (17,000) (17,000) (17,000)
Net loss (3,213,000) (3,184,000) (3,184,000) (29,000)
Balance at Jan. 31, 2025 $ 16,713,000 $ 322,000 $ 261,470,000 $ (243,934,000) $ (6,000) $ 17,852,000 $ (1,139,000)
Balance, shares at Jan. 31, 2025   32,196,862